Evidence map›Paper›PMID 30096780›Full record

ArticleInternational journal of molecular sciences2018

Non-Ionizing Radiation for Cardiac Human Amniotic Mesenchymal Stromal Cell Commitment: A Physical Strategy in Regenerative Medicine.

Mario Ledda, Enrico D'Emilia, Maria Grazia Lolli, Rodolfo Marchese, Claudio De Lazzari, Antonella Lisi

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mario LeddaInstitute of Translational Pharmacology, National Research Council, (CNR), via del Fosso del Cavaliere 100, 00133 Rome, Italy. mario.ledda@ift.cnr.it.
Enrico D'EmiliaDipartimento Innovazioni Tecnologiche (INAIL-DIT), Via Fontana Candida 1, Monte Porzio Catone, 00078 Rome, Italy. e.demilia@inail.it.
Maria Grazia LolliInstitute of Translational Pharmacology, National Research Council, (CNR), via del Fosso del Cavaliere 100, 00133 Rome, Italy. mariagrazia.lolli@ift.cnr.it.ORCID 0000-0002-6834-2643
Rodolfo MarcheseResearch Center, FBF S. Peter Hospital, Via Cassia 600, 00189 Rome, Italy. marchese.rodolfo@fbfrm.it.
Claudio De LazzariInstitute of Clinical Physiology, National Research Council, (CNR), Via Palestro 32, 00185 Rome, Italy. dela@ifc.cnr.it.ORCID 0000-0001-5149-4109
Antonella LisiInstitute of Translational Pharmacology, National Research Council, (CNR), via del Fosso del Cavaliere 100, 00133 Rome, Italy. antonella.lisi@ift.cnr.it.
Istituto di Farmacologia Traslazionale · ITIstituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro · ITNational Research Council · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell therapy is an innovative strategy for tissue repair, since adult stem cells could have limited regenerative ability as in the case of myocardial damage. This leads to a local contractile dysfunction due to scar formation. For these reasons, refining strategy approaches for "in vitro" stem cell commitment, preparatory to the "in vivo" stem cell differentiation, is imperative. In this work, we isolated and characterized at molecular and cellular level, human Amniotic Mesenchymal Stromal Cells (hAMSCs) and exposed them to a physical Extremely Low Frequency Electromagnetic Field (ELF-EMF) stimulus and to a chemical Nitric Oxide treatment. Physically exposed cells showed a decrease of cell proliferation and no change in metabolic activity, cell vitality and apoptotic rate. An increase in the mRNA expression of cardiac and angiogenic differentiation markers, confirmed at the translational level, was also highlighted in exposed cells. Our data, for the first time, provide evidence that physical ELF-EMF stimulus (7 Hz, 2.5 µT), similarly to the chemical treatment, is able to trigger hAMSC cardiac commitment. More importantly, we also observed that only the physical stimulus is able to induce both types of commitments contemporarily (cardiac and angiogenic), suggesting its potential use to obtain a better regenerative response in cell-therapy protocols.

Indexed as

Regenerative MedicineAmnionCell- and Tissue-Based TherapyCell DifferentiationCell ProliferationElectromagnetic FieldsGene Expression Regulation, DevelopmentalHeartHumansMesenchymal Stem CellsRadiation, NonionizingRNA, MessengerRNA, Messengerangiogenic commitmentcardiac commitmentELF-EMFhAMSCsNitric Oxideregenerative medicine

Identifiers

PMID30096780
PMCPMC6121454
OpenAlexW2885727366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.